|
UBE2J1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.011500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.32970000000932E-05 |
| Normal-vs-Stage2 |
5.434000E-02 |
| Normal-vs-Stage3 |
3.393000E-01 |
| Normal-vs-Stage4 |
3.266800E-01 |
| Stage1-vs-Stage2 |
5.749400E-01 |
| Stage1-vs-Stage3 |
9.121600E-02 |
| Stage1-vs-Stage4 |
4.494800E-01 |
| Stage2-vs-Stage3 |
4.070600E-01 |
| Stage2-vs-Stage4 |
7.384800E-01 |
| Stage3-vs-Stage4 |
7.488400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.94119999999254E-05 |
| Normal-vs-AfricanAmerican |
7.482200E-02 |
| Normal-vs-Asian |
5.786400E-02 |
| Caucasian-vs-AfricanAmerican |
1.068150E-01 |
| Caucasian-vs-Asian |
9.876000E-01 |
| AfricanAmerican-vs-Asian |
5.941600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.28520000000021E-05 |
| Normal-vs-Female |
1.692820E-01 |
| Male-vs-Female |
3.097700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.838270E-02 |
| Normal-vs-Extreme_Weight |
4.08320000000462E-05 |
| Normal-vs-Obese |
5.075500E-02 |
| Normal-vs-Extreme_Obese |
4.770300E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.760800E-01 |
| Normal_Weight-vs-Obese |
4.398200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.640000E-01 |
| Extreme_Weight-vs-Obese |
7.913700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.047200E-01 |
| Obese-vs-Extreme_Obese |
1.243050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.434800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.522300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.50075999999499E-05 |
| Normal-vs-Age(81-100Yrs) |
3.70520000000374E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.679800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.931900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.577670E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.560100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.853700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.905030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.377200E-04 |
| Normal-VS-Type2 PRCC |
4.47670000000011E-05 |
| Normal-VS-KIRP CIMP |
2.270200E-01 |
| Normal-VS-Unclassified PRCC |
4.055200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.359210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.996200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.538200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.895390E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.166760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.032600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31340000000912E-06 |
| Normal-vs-N1 |
4.921000E-01 |
| Normal-vs-N2 |
4.92400009655114E-10 |
| N0-vs-N1 |
2.01089999999349E-05 |
| N0-vs-N2 |
1.145560E-02 |
| N1-vs-N2 |
8.63040000020909E-07 |
|
|
